Hucke, A.; Kantauskaite, M.; Köpp, T.N.; Wehe, C.A.; Karst, U.; Nedvetsky, P.I.; Ciarimboli, G.
Modulating the Activity of the Human Organic Cation Transporter 2 Emerges as a Potential Strategy to Mitigate Unwanted Toxicities Associated with Cisplatin Chemotherapy. Int. J. Mol. Sci. 2024, 25, 2922.
https://doi.org/10.3390/ijms25052922
AMA Style
Hucke A, Kantauskaite M, Köpp TN, Wehe CA, Karst U, Nedvetsky PI, Ciarimboli G.
Modulating the Activity of the Human Organic Cation Transporter 2 Emerges as a Potential Strategy to Mitigate Unwanted Toxicities Associated with Cisplatin Chemotherapy. International Journal of Molecular Sciences. 2024; 25(5):2922.
https://doi.org/10.3390/ijms25052922
Chicago/Turabian Style
Hucke, Anna, Marta Kantauskaite, Tim N. Köpp, Christoph A. Wehe, Uwe Karst, Pavel I. Nedvetsky, and Giuliano Ciarimboli.
2024. "Modulating the Activity of the Human Organic Cation Transporter 2 Emerges as a Potential Strategy to Mitigate Unwanted Toxicities Associated with Cisplatin Chemotherapy" International Journal of Molecular Sciences 25, no. 5: 2922.
https://doi.org/10.3390/ijms25052922
APA Style
Hucke, A., Kantauskaite, M., Köpp, T. N., Wehe, C. A., Karst, U., Nedvetsky, P. I., & Ciarimboli, G.
(2024). Modulating the Activity of the Human Organic Cation Transporter 2 Emerges as a Potential Strategy to Mitigate Unwanted Toxicities Associated with Cisplatin Chemotherapy. International Journal of Molecular Sciences, 25(5), 2922.
https://doi.org/10.3390/ijms25052922
